References
- Hindle M, Newton DAG, Chrystyn H. Investigation of an optimal inhaler technique with use of urinary salbutamol excretion as a measure of relative bioavailability to the lung. Thorax 1993;48:607–640
- Bisgaard H, Klug B, Sumby BS, Burnell PK. Fine particle mass from Diskus inhaler and Turbuhaler inhaler in children with asthma. Eur Respir J 1998;11:1111–1115
- Everard ML, Devadason SG, Le Souef PN. Flow early in the inspiratory manoeuvre affects the aerosol particle size distribution from a Turbuhaler. Respir Med 1997;91:624–628
- Frijlink HW, De Boer AH. Dry powder inhalers for pulmonary drug delivery. Expert Opin Drug Deliv 2004;1:67–86
- Hill LS, Slater AL. A comparison of the performance of two modern multidose dry powder asthma inhalers. Respir Med 1998;92:105–110
- Palander A, Matila T, Karhu M, Muttonen E. In vitro comparison of three salbutamol-containing multidose dry powder inhalers: Buventol Easyhaler, Inspiryl Turbuhaler and Venetolin Diskus. Clin Drug Invest 2000;20:25–33
- Prime DJ, Grant AC, Slater AL, Woodhouse RN. A critical comparison of the does delivery characteristics of four alternative inhalation devices delivering salbutamol: pressurized metered dose inhaler, Diskus inhaler, Diskhaler inhaler and Turbuhaler inhaler. J Aerosol Med 1999;12:75–84
- Brunell PKP, Small T, Doig S, Johal B, Jenkins R, Gibson GJ. Ex-vivo product performance of Diskus and Turbuhaler inhalers using inhalation profiles from patients with severe chronic obstructive pulmonary disease. Respir Med 2001;95:324–330
- Weiner PP, Weiner M. Inspiratory muscle training may increase peak inspiratory flow in chronic obstructive pulmonary disease. Respiration 2006;73:151–156
- Van der Palen J. Peak inspiratory flow through Diskus and Turbuhaler, measured by means of a peak inspiratory flow meter (In-Check dial). Respir Med 2003;97:285–289
- Al-Showair RAM, Tarsin WY, Assi KH, Pearson SB, Chrystyn H. Can all patients with COPD use the correct inhalation flow with all inhalers and does training help? Respir Med 2007;101:2395–2401
- Brown PH, Ning ACWS, Greening AP, McLean A, Crompton GK. Peak inspiratory flow through Turbuhaler in acute asthma. Eur Respir J 1995;8:1940–1941
- Tarsin WY, Pearson SB, Assi KH, Chrystyn H. Emitted dose estimates from Seretide Diskus and Symbicort Turbuhaler following inhalation by severe asthmatics. J Aerosol Med 2006;19:131–137
- Kondo T, Tanigaki T, Tajiri S, Ohe M, Hibino M, Akazawa K. Profiles of inhaled flow from dry powder inhalers in subjects unfamiliar with the device. Jpn J Pharm Health Care Sci 2014;40:344–351
- Laube BL, Janssens HM, de Jongh FHC, Devadason SG, Dhand R, Diot P, Everard ML, et al. What the pulmonary specialists should know about new inhalation therapies? Eur Respir J 2011;37:1308–1331
- Kondo T, Tanigaki T, Tazaki G, Watanabe H, Ishii H, Tsunoda T, Uruma T. The relation between inspiratory pressure and flow through dry powder inhaler available in Japan. Jpn J Allergol 2010;59:950–955
- Kanabuchi K, Kondo T, Tanigaki T, Tajiri S, Hayama N, Takahari Y, Iwao K. Minimal inspiratory flow from dry powder inhalers according to biphasic model of pressure vs. flow relationship. Tokai J Exp Clin Med 2011;36:1–4
- Windisch W, Hennings E, Sorichter S, Hamm H, Criée CP. Peak or plateau maximal inspiratory mouth pressure: which is best? Eur Respir J 2004;23:708–713